The Diagnosis and Management of Hyperthyroidism in Korea: Consensus Report of the Korean Thyroid Association

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2014 Jan 8

PMID 24396691

Citations 46

Authors

Jae Hoon Moon

Ka Hee Yi

Affiliations

Soon will be listed here.

Abstract

Hyperthyroidism is one of the causes of thyrotoxicosis and the most common cause of hyperthyroidism in Korea is Graves disease. The diagnosis and treatment of Graves disease are different according to geographical area. Recently, the American Thyroid Association and the American Association of Clinical Endocrinologists suggested new management guidelines for hyperthyroidism. However, these guidelines are different from clinical practice in Korea and are difficult to apply. Therefore, the Korean Thyroid Association (KTA) conducted a survey of KTA members regarding the diagnosis and treatment of hyperthyroidism, and reported the consensus on the management of hyperthyroidism. In this review, we summarized the KTA report on the contemporary practice patterns in the diagnosis and management of hyperthyroidism, and compared this report with guidelines from other countries.

Citing Articles

Treatment of Graves' Disease: Faster Remission or Longer but Safe, That Is the Question.

Jung C Endocrinol Metab (Seoul). 2025; 40(1):70-72.

PMID: 40017326 PMC: 11898309. DOI: 10.3803/EnM.2025.2333.

Treatment Patterns and Preferences for Graves' Disease in Korea: Insights from a Nationwide Cohort Study.

Kim K, Choi J, Shin S, Kim J, Kim K, Kim S Endocrinol Metab (Seoul). 2024; 39(4):659-663.

PMID: 39099390 PMC: 11375296. DOI: 10.3803/EnM.2024.2042.

MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.

Peng C, Lin Y, Lee S, Lin S, Han C, Loh C JAMA Netw Open. 2024; 7(3):e240904.

PMID: 38436957 PMC: 10912964. DOI: 10.1001/jamanetworkopen.2024.0904.

Effects of altitude on thyroid disorders according to Chinese three-rung, ladder-like topography: national cross-sectional study.

Gong B, Wang Y, Zhang J, Zhang Q, Zhao J, Li J BMC Public Health. 2024; 24(1):26.

PMID: 38167020 PMC: 10762831. DOI: 10.1186/s12889-023-17569-5.

A machine learning-assisted system to predict thyrotoxicosis using patients' heart rate monitoring data: a retrospective cohort study.

Shin K, Kim J, Park J, Oh T, Kong S, Ahn C Sci Rep. 2023; 13(1):21096.

PMID: 38036639 PMC: 10689821. DOI: 10.1038/s41598-023-48199-x.

References

Abraham P, Avenell A, Park C, Watson W, Bevan J . A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol. 2005; 153(4):489-98. DOI: 10.1530/eje.1.01993. View

Klein I, Danzi S . Thyroid disease and the heart. Circulation. 2007; 116(15):1725-35. DOI: 10.1161/CIRCULATIONAHA.106.678326. View

Abraham-Nordling M, Torring O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J . Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005; 15(11):1279-86. DOI: 10.1089/thy.2005.15.1279. View

Pedersen I, Knudsen N, Perrild H, Ovesen L, Laurberg P . TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf). 2001; 55(3):381-90. DOI: 10.1046/j.1365-2265.2001.01347.x. View

Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T . Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. J Clin Endocrinol Metab. 1987; 65(2):359-63. DOI: 10.1210/jcem-65-2-359. View

Bahn Chair R, Burch H, Cooper D, Garber J, Greenlee M, Klein I . Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011; 21(6):593-646. DOI: 10.1089/thy.2010.0417. View

Klein I, Becker D, LEVEY G . Treatment of hyperthyroid disease. Ann Intern Med. 1994; 121(4):281-8. DOI: 10.7326/0003-4819-121-4-199408150-00010. View

Mazza E, Carlini M, Flecchia D, Blatto A, Zuccarini O, Gamba S . Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study. J Endocrinol Invest. 2008; 31(10):866-72. DOI: 10.1007/BF03346433. View

Bogazzi F, Vitti P . Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease?. Nat Clin Pract Endocrinol Metab. 2007; 4(2):70-1. DOI: 10.1038/ncpendmet0692. View

10.

Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y . Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid. 1991; 1(2):129-35. DOI: 10.1089/thy.1991.1.129. View

11.

Nakamura H . [Guideline for the treatment of Graves' disease with antithyroid drug]. Nihon Rinsho. 2006; 64(12):2189-93. View

12.

Brucker-Davis F, Skarulis M, Grace M, Benichou J, Hauser P, Wiggs E . Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med. 1995; 123(8):572-83. DOI: 10.7326/0003-4819-123-8-199510150-00002. View

13.

Rajatanavin R, Liberman C, Lawrence G, DArcangues C, Young R, Emerson C . Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma. J Clin Endocrinol Metab. 1985; 61(1):17-21. DOI: 10.1210/jcem-61-1-17. View

14.

Moon J, Yi K . The diagnosis and management of hyperthyroidism in Korea: consensus report of the korean thyroid association. Endocrinol Metab (Seoul). 2014; 28(4):275-9. PMC: 3871036. DOI: 10.3803/EnM.2013.28.4.275. View

15.

Gozu H, Lublinghoff J, Bircan R, Paschke R . Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Mol Cell Endocrinol. 2010; 322(1-2):125-34. DOI: 10.1016/j.mce.2010.02.001. View

16.

Valdes Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J . The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol. 2003; 148(4):433-42. DOI: 10.1530/eje.0.1480433. View

17.

Boelaert K, Torlinska B, Holder R, Franklyn J . Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab. 2010; 95(6):2715-26. DOI: 10.1210/jc.2009-2495. View

18.

Cooper D . Antithyroid drugs. N Engl J Med. 2005; 352(9):905-17. DOI: 10.1056/NEJMra042972. View